FDA
approval
· 2025-12-09
FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
Summary
The FDA approved a supplemental application for Imitrex (sumatriptan) submitted by GlaxoSmithKline LLC. This approval updates the product's labeling per the sup…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IMITREX (SUMATRIPTAN)